Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | PLA2G4B | P0C869 | 8/20 | 0.61 |
| ▸ | RARB | P10826 | 4/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19027823 | 0.86 | MAPT (0.62) | TP53TSHRMAPK1HTTTDP1 | |
| SCHEMBL2180731 | 0.82 | TP53 (0.82) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL14097198 | 0.82 | TP53 (0.82) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL7911508 | 0.82 | TP53 (0.82) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL209561 | 0.82 | TP53 (0.82) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL26136333 | 0.82 | TP53 (0.82) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL2181009 | 0.82 | TP53 (0.82) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL2183388 | 0.82 | TP53 (0.82) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL1952122 | 0.80 | TP53 (0.79) | TP53TSHRPLA2G4BRARBMAPK1 | |
| SCHEMBL10535685 | 0.80 | RARB (0.88) | TP53TSHRPLA2G4BRARBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112805353-B | Liquid crystal mixture and liquid crystal display | 默克专利股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-108368425-B | Liquid crystal mixture and liquid crystal display | 默克专利股份有限公司（DE） | 2023-01-13 | — | — | CN | disclosed |
| CN-114702965-A | Liquid crystal mixture and liquid crystal display | 默克专利股份有限公司 | 2022-07-05 | — | — | CN | disclosed |
| US-20220106525-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2022-04-07 | — | — | US | disclosed |
| EP-3864111-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2021-08-18 | — | — | EP | disclosed |
| US-11053442-B2 | Liquid crystal mixture and liquid crystal display | MERCK PATENT GMBH (DE) | 2021-07-06 | — | — | US | disclosed |
| US-11053442-B2 | Liquid crystal mixture and liquid crystal display | MERCK PATENT GMBH (DE) | 2021-07-06 | — | — | US | disclosed |
| CN-112805353-A | Liquid crystal mixture and liquid crystal display | 默克专利股份有限公司 | 2021-05-14 | — | — | CN | disclosed |
| US-20200255740-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2020-08-13 | — | — | US | disclosed |
| US-20200255740-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2020-08-13 | — | — | US | disclosed |
| EP-3390570-B1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2020-03-18 | — | — | EP | disclosed |
| EP-3390570-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017102068-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017102068-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220106525-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | CXCR1, PYM1, F11 | TP53 925/4885TSHR 3248/4885PLA2G4B 2454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.